Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?

Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?

Bibliographic Details
Main Authors:	Boyd Kathleen A, Briggs Andrew H, Paul Jim, Iveson Tim, Midgely Rachel, Harkin Andrea, Bates Gaynor, Alexander Laura, Cassidy Jim
Format:	Article
Language:	English
Published:	BMC 2011-12-01
Series:	Trials

Similar Items

Choice of randomisation time-point in non-inferiority studies of reduced treatment duration: experience from the SCOT study
by: Paul Jim, et al.
Published: (2011-12-01)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
by: Bengt Glimelius, et al.
Published: (2020-08-01)

Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer
by: Antonia K Roseweir, et al.
Published: (2020-10-01)

The effect of adjuvant chemotherapy in stage 2 colorectal cancer
by: hormoz Mahmoudvand, et al.
Published: (2014-06-01)

Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis
by: Diana Groza, et al.
Published: (2018-05-01)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
by: Yuji Miyamoto, et al.
Published: (2020-11-01)

Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event
by: Henriette Quack, et al.
Published: (2013-12-01)

The Aetiology of Delay to Commencement of Adjuvant Chemotherapy following Colorectal Resection
by: G. S. Simpson, et al.
Published: (2014-01-01)

Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer
by: Visvikis A, et al.
Published: (2020-02-01)

Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer
by: Michelle C. M. Lee, et al.
Published: (2021-08-01)

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT
by: Timothy Iveson, et al.
Published: (2019-12-01)

Evolution of Adjuvant Chemotherapy and Efficacy of Commonly Used Regimens in Colorectal Cancer
by: S.M. Adiga, et al.
Published: (2012-04-01)

Colorectal cancer surgery patients received adjuvant chemotherapy investigate the effectiveness
by: Yi-Ju Huang, et al.
Published: (2015)

「Love is Only When We Meet」 A Study on Stop-Motion and Techniques
by: Jung-Ting Hsu, et al.
Published: (2008)

STRAP Is a Strong Predictive Marker of Adjuvant Chemotherapy Benefit in Colorectal Cancer
by: Martin Buess, et al.
Published: (2004-11-01)

Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer
by: Keisuke Ihara, et al.
Published: (2019-04-01)

Predictive impact of the inflammation‐based indices in colorectal cancer patients with adjuvant chemotherapy
by: Yong Tao, et al.
Published: (2018-07-01)

Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases
by: M.‐A. Allard, et al.
Published: (2019-10-01)

Stop turning a blind eye!
by: Jim A. Reekers
Published: (2021-10-01)

The “addition” and “subtraction” of adjuvant chemotherapy for locally advanced colorectal cancer: where to go next?
by: Xin-Hua Chen, et al.
Published: (2019-10-01)

Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases
by: Luigi Rossi, et al.
Published: (2012-06-01)

Immunological nomograms predicting prognosis and guiding adjuvant chemotherapy in stage II colorectal cancer
by: Feng Y, et al.
Published: (2019-08-01)

Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer.
by: Hiroki Osumi, et al.
Published: (2017-01-01)

Congenital Mesoblastic Nephroma in a Premature Neonate: Should We Give Adjuvant Chemotherapy?
by: Kechiche Nahla, et al.
Published: (2019-12-01)

When do stop-loss rules stop losses?
by: Kaminski, Kathryn M., et al.
Published: (2018)

Chemotherapy and adverse cardiovascular events in colorectal cancer patients undergoing surgical resection
by: Chieh Yang Koo, et al.
Published: (2021-01-01)

Patients’ experience of communication and handling of symptomatic adverse events in breast cancer patients receiving adjuvant chemotherapy
by: Christina Witt Bæksted, et al.
Published: (2019-11-01)

When to start and when to stop antifibrotic therapies
by: Sebastiano Emanuele Torrisi, et al.
Published: (2017-10-01)

A Study of Symptom Clusters and Self-Care Experience of Colorectal Cancer Patients Adjuvant with Chemotherapy
by: HUANG, PEI,CHEN, et al.
Published: (2013)

Long‐term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy
by: Kristine Bennedsgaard, et al.
Published: (2020-07-01)

Effectiveness of adjuvant chemotherapy in patients with Stage II colorectal cancer: A multicenter retrospective study
by: Hasan Jalaeikhoo, et al.
Published: (2019-01-01)

Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer
by: Reetta Holma, et al.
Published: (2020-02-01)

Adjuvant chemotherapy for colorectal cancer: age differences in factors influencing patients' treatment decisions
by: Jorgensen ML, et al.
Published: (2013-08-01)

Predictive models of adjuvant chemotherapy for patients with stage ii colorectal cancer: A retrospective study
by: Bo Wei, et al.
Published: (2017-01-01)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
by: Chen, Y., et al.
Published: (2022)

When Should Statins Be Stopped?
by: Mário Bibi, et al.
Published: (2021-06-01)

The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people
by: Adam Todd, et al.
Published: (2018-11-01)

Adjuvant chemotherapy for gastric cancer
by: I. P. Kolesnyk, et al.
Published: (2015-12-01)

Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer
by: Zuo Fei, et al.
Published: (2019-04-01)

Molecular marker identification for relapse prediction in 5-FU-based adjuvant chemotherapy in gastric and colorectal cancers.
by: Kazushige Ishida, et al.
Published: (2012-01-01)